查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1917981

睡眠监测设备市场－2026-2031年预测

Sleep Monitoring Devices Market - Forecast from 2026 to 2031
出版日期: | 出版商: Knowledge Sourcing Intelligence | 英文 145 Pages | 商品交期: 最快1-2个工作天内

价格
简介目录

预计睡眠监测设备市场将从 2025 年的 261.56 亿美元成长到 2031 年的 390.05 亿美元，复合年增长率为 6.89%。

睡眠监测设备涵盖了成熟的消费级穿戴装置（腕带、戒指、智慧型手錶）、近距离设备（床边雷达、床垫下压电感测器、智慧枕头）以及临床级多导睡眠图（PSG）相关系统。关键测量指标正逐步标准化：活动记录器、光电容积脉搏波描记法（PPG）（用于测量心率变异性）、血氧饱和度（SpO2）、呼吸努力程度、体温，以及透过干电极头带或耳内感测器取得的脑电图（EEG）睡眠分期。

穿戴式装置占总销量的 85% 以上，约占总收入的 70%。 Oura Ring Gen 3、Whoop 4.0、Fitbit Sense 2/Charge 6、Apple Watch Series 9/Ultra 2、Samsung Galaxy Watch 7 和 Garmin Vivosmart/Venu 系列目前均提供检验的睡眠分期准确度，与多导睡眠图 (PSG) 测量结果相比，浅睡眠、深睡眠和快速眼动图 (REM12 ±12%持续的血氧饱和度 (SpO2) 和呼吸频率监测已成为必备功能，从而可以对人群阻塞型睡眠呼吸中止症中止症 (ESA)筛检。据估计，ESA 在成人中的盛行率为 15-30%，而未确诊率超过 80%。

成长要素在于人们对睡眠障碍的认识不断提高以及报销途径的不断拓展。在美国，医疗保险和医疗补助服务中心 (CMS) 于 2024 年新增了对某些获得 FDA 批准的可穿戴睡眠诊断设备的有限报销，而私人保险公司（如 UnitedHealthcare 和 Aetna）现在已将基于 watchPAT 的家庭睡眠呼吸中止症检测作为一级证据。同样，欧洲的 DiGA 加速核准系统和英国NHS 数位健康技术路径也使得检验的数位睡眠药物（如 Somryst 和 Sleepio）及其配套诊断产品能够获得报销。

临床应用在循环系统和神经病学领域最为迅速。夜间连续心率变异性 (HRV) 和血氧饱和度 (SpO2) 数据正被整合到远端患者监护(RPM) 工作流程中，用于心臟衰竭和中风后患者的监测（CPT 代码 99457/99458）。癫痫中心正在使用多模态穿戴装置进行与癫痫发作相关的睡眠片段化分析。居家医院计画也越来越多地采用获得 FDA 批准的近穿戴式装置（例如 Withings Sleep Analyzer 和 ResMed NightOwl），以降低病患的再入院风险。

市场分为两个消费者群体：

  • 高阶产品（300-550美元）－Oura、Whoop、Ultrahuman Ring Air、Eight Sleep Pod。这些产品着重于恢復评分、基于心率变异性（HRV）的训练负荷以及与温度调节床垫的整合。
  • 福斯市价位（80-250美元）－小米手环9、Amazfit、Fitbit。这些型号主打14-21天的续航时间，并提供基本的睡眠阶段和血氧饱和度追踪功能。

人们对睡眠监测设备的准确性期望值正在急剧上升。包括史丹佛大学、哈佛大学和鲁汶大学在内的独立检验研究，经常将消费级设备与多导睡眠图（PSG）进行比较，顶级设备在四个睡眠阶段（清醒/浅睡眠/深睡眠/快速眼动睡眠）的准确率均达到82-88%（相比之下，医用活动记录仪的准确率超过90%）。製造商则透过混合机器学习模型（这些模型基于数百万个夜晚的睡眠资料进行训练）和持续的韧体更新来应对这项挑战。

隐私和资料所有权正在成为新的差异化因素：本地设备内处理（Apple S9/SiP、Google Tensor）无需云端上传即可进行睡眠分期，而免订阅模式（Garmin、Withings）正在从 Whoop 和 Oura 的定期收费结构中重新夺回市场份额。

总之，睡眠监测设备市场已跨越临界点，从健康小工具转型为临床实用工具。成功越来越依赖以下三个方面：(1) 透过多导睡眠图 (PSG)检验，准确检测睡眠呼吸中止症和昼夜节律生物标记；(2) 无缝整合到远端病患管理 (RPM) 和慢性病管理工作流程中，并提供可报销的资料输出；(3) 在支付方和雇主对生物辨识资料建置权限不断扩大的时代，可靠的隐私保护；(3) 在支付方和雇主对生物辨识资料建置权限不断扩大的时代，可靠的隐私保护架构。随着睡眠从生活方式指标转变为标准生命体征，那些将医疗级感测器融合技术与符合人体工学的消费者友好型设计以及清晰的监管和报销途径相结合的公司，将获得最大的市场价值。

本报告的主要优势：

  • 深入分析：取得以客户群、政府政策和社会经济因素、消费者偏好、垂直产业和其他细分市场为重点的深入市场洞察，涵盖主要地区和新兴地区。
  • 竞争格局：了解主要企业采取的策略倡议，并了解透过正确的策略打入市场的潜力。
  • 市场驱动因素与未来趋势：探索动态因素和关键市场趋势，以及它们将如何塑造未来的市场发展。
  • 可执行的建议：利用洞察力为策略决策提供讯息，从而在动态环境中开拓新的业务管道和收入来源。
  • 受众范围广：对新兴企业、研究机构、顾问公司、中小企业和大型企业都有益处且经济高效。

它是用来做什么的？

产业与市场洞察、商业机会评估、产品需求预测、打入市场策略、地理扩张、资本投资决策、法律规范及其影响、新产品开发、竞争影响

分析范围

  • 历史资料（2021-2025 年）和预测资料（2026-2031 年）
  • 成长机会、挑战、供应链前景、法规结构、客户行为和趋势分析
  • 竞争对手定位、策略和市场占有率分析
  • 按业务板块和地区（国家）分類的收入成长和预测分析
  • 公司概况（策略、产品、财务资讯、关键趋势等）

目录

第一章执行摘要

第二章市场概述

  • 市场概览
  • 市场定义
  • 分析范围
  • 市场区隔

第三章 商业情境

  • 市场驱动因素
  • 市场限制
  • 市场机会
  • 波特五力分析
  • 产业价值链分析
  • 政策和法规
  • 策略建议

第四章 技术展望

第五章：依产品类型分類的睡眠监测设备市场

  • 介绍
  • 穿戴式装置
    • 手錶类型/腕带类型
    • 环形
    • 耳机类型
    • 其他的
  • 不可穿戴
    • 床感测器
    • 床边设备

6. 按分销管道分類的睡眠监测设备市场

  • 介绍
  • 在线的
  • 离线

7. 按地区分類的睡眠监测设备市场

  • 介绍
  • 北美洲
    • 我们
    • 加拿大
    • 墨西哥
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他的
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 西班牙
    • 其他的
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 其他的
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 韩国
    • 印尼
    • 泰国
    • 其他的

第八章 竞争格局与分析

  • 主要企业和策略分析
  • 市占率分析
  • 企业合併、协议、商业合作
  • 竞争对手仪錶板

第九章：公司简介

  • Sleep Number
  • Rise Science
  • Dream
  • The French Aerospace Lab-ONERA
  • Motive Inc.
  • Oxehealth
  • Eight Sleep
  • iHealth Labs

第十章附录

  • 货币
  • 先决条件
  • 基准年和预测年时间表
  • 相关人员的主要收益
  • 分析方法
  • 简称
简介目录
Product Code: KSI061615352

Sleep Monitoring Devices Market is projected to expand at a 6.89% CAGR, achieving USD 39.005 billion in 2031 from USD 26.156 billion in 2025.

Sleep monitoring devices encompass a maturing ecosystem of consumer wearables (wristbands, rings, smartwatches), nearables (bedside radar, under-mattress piezo sensors, smart pillows), and clinical-grade PSG-adjacent systems. Core metrics have standardized around actigraphy, photoplethysmography (PPG) heart-rate variability, SpO2, respiratory effort, body temperature, and, increasingly, EEG-derived sleep staging via dry-electrode headbands or in-ear sensors.

Wearables dominate >85 % of unit volume and ≈70 % of revenue. Oura Ring Gen 3, Whoop 4.0, Fitbit Sense 2/Charge 6, Apple Watch Series 9/Ultra 2, Samsung Galaxy Watch 7, and Garmin Vivosmart/Venu lines now deliver validated sleep-staging accuracy within +-10-12 % of PSG for light/deep/REM classification. Continuous SpO2 and respiratory-rate tracking have become table stakes, enabling population-level screening for undiagnosed obstructive sleep apnea (estimated prevalence 15-30 % in adults, >80 % undiagnosed).

The primary growth driver remains the convergence of rising sleep-disorder awareness with expanding reimbursement pathways. In the U.S., CMS added limited coverage for certain FDA-cleared wearable-derived sleep diagnostics in 2024, while private payors (UnitedHealthcare, Aetna) now recognize watchPAT-style home sleep apnea testing as Tier 1 evidence. Europe's DiGA fast-track and NHS Digital Health Technology pathways have similarly opened reimbursement for validated digital sleep therapeutics (Somryst, Sleepio) and companion diagnostics.

Clinical adoption is accelerating fastest in cardiology and neurology. Continuous nocturnal HRV and SpO2 data are now integrated into remote patient monitoring (RPM) CPT 99457/99458 workflows for heart-failure and post-stroke patients, while epilepsy centers use multimodal wearables for seizure-related sleep fragmentation analysis. Hospital-at-home programs increasingly deploy FDA-cleared nearables (Withings Sleep Analyzer, ResMed NightOwl) to reduce readmission risk.

Consumer segmentation has bifurcated:

  • Premium tier ($300-550) - Oura, Whoop, Ultrahuman Ring Air, Eight Sleep Pod, focusing on recovery scores, HRV-guided training load, and temperature-regulated bedding integration.
  • Mass tier ($80-250) - Xiaomi Mi Band 9, Amazfit, Fitbit, emphasizing 14-21 day battery life and basic sleep-stage + SpO2 tracking.

Accuracy expectations have risen sharply. Independent validation studies (e.g., Stanford, Harvard, KU Leuven) now routinely benchmark consumer devices against PSG, with top performers achieving 82-88 % four-stage (wake/light/deep/REM) Cohen's kappa versus 90 %+ for medical actigraphy. Manufacturers have responded with hybrid machine-learning models trained on multi-million-night datasets and continuous firmware updates.

Privacy and data ownership are emerging differentiators. Local-on-device processing (Apple S9/SiP, Google Tensor) now enables sleep staging without cloud upload, while subscription-free models (Garmin, Withings) are regaining share against Whoop and Oura's recurring-fee structures.

In conclusion, the sleep monitoring device market has crossed the inflection point from wellness gadget to clinically actionable tool. Success increasingly hinges on three capabilities: (1) validated accuracy against PSG for sleep apnea and circadian biomarkers, (2) seamless integration into RPM and chronic-disease management workflows with reimbursable data outputs, and (3) defensible privacy architecture in an era of expanding payer and employer access to biometric data. Companies that combine medical-grade sensor fusion with consumer-grade ergonomics and clear regulatory/reimbursement pathways will capture the lion's share of value as sleep moves from lifestyle metric to standard-of-care vital sign.

Key Benefits of this Report:

  • Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, and other sub-segments.
  • Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
  • Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape future market developments.
  • Actionable Recommendations: Utilize the insights to exercise strategic decisions to uncover new business streams and revenues in a dynamic environment.
  • Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

  • Historical data from 2021 to 2025 & forecast data from 2026 to 2031
  • Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, and Trend Analysis
  • Competitive Positioning, Strategies, and Market Share Analysis
  • Revenue Growth and Forecast Assessment of segments and regions including countries
  • Company Profiling (Strategies, Products, Financial Information), and Key Developments among others.

Sleep Monitoring Devices Market Segmentation:

  • By Product Type
  • Wearable
  • Watches And Wrist Bands
  • Rings
  • Earbuds
  • Others
  • Non-Wearable
  • Bed Sensors
  • Bed Side Devices
  • By Distribution Channel
  • Online
  • Offline
  • By Geography
  • North America
  • USA
  • Canada
  • Mexico
  • South America
  • Brazil
  • Argentina
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Spain
  • Others
  • Middle East and Africa
  • Saudi Arabia
  • UAE
  • Others
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Thailand
  • Others

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

2. MARKET SNAPSHOT

  • 2.1. Market Overview
  • 2.2. Market Definition
  • 2.3. Scope of the Study
  • 2.4. Market Segmentation

3. BUSINESS LANDSCAPE

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Porter's Five Forces Analysis
  • 3.5. Industry Value Chain Analysis
  • 3.6. Policies and Regulations
  • 3.7. Strategic Recommendations

4. TECHNOLOGICAL OUTLOOK

5. SLEEP MONITORING DEVICES MARKET BY PRODUCT TYPE

  • 5.1. Introduction
  • 5.2. Wearable
    • 5.2.1. Watched And Wrist Bands
    • 5.2.2. Rings
    • 5.2.3. Earbuds
    • 5.2.4. Others
  • 5.3. Non-Wearable
    • 5.3.1. Bed Sensors
    • 5.3.2. Bed Side Devices

6. SLEEP MONITORING DEVICES MARKET BY DISTRIBUTION CHANNEL

  • 6.1. Introduction
  • 6.2. Online
  • 6.3. Offline

7. SLEEP MONITORING DEVICES MARKET BY GEOGRAPHY

  • 7.1. Introduction
  • 7.2. North America
    • 7.2.1. USA
    • 7.2.2. Canada
    • 7.2.3. Mexico
  • 7.3. South America
    • 7.3.1. Brazil
    • 7.3.2. Argentina
    • 7.3.3. Others
  • 7.4. Europe
    • 7.4.1. Germany
    • 7.4.2. France
    • 7.4.3. United Kingdom
    • 7.4.4. Spain
    • 7.4.5. Others
  • 7.5. Middle East and Africa
    • 7.5.1. Saudi Arabia
    • 7.5.2. UAE
    • 7.5.3. Others
  • 7.6. Asia Pacific
    • 7.6.1. China
    • 7.6.2. India
    • 7.6.3. Japan
    • 7.6.4. South Korea
    • 7.6.5. Indonesia
    • 7.6.6. Thailand
    • 7.6.7. Others

8. COMPETITIVE ENVIRONMENT AND ANALYSIS

  • 8.1. Major Players and Strategy Analysis
  • 8.2. Market Share Analysis
  • 8.3. Mergers, Acquisitions, Agreements, and Collaborations
  • 8.4. Competitive Dashboard

9. COMPANY PROFILES

  • 9.1. Sleep Number
  • 9.2. Rise Science
  • 9.3. Dream
  • 9.4. The French Aerospace Lab-ONERA
  • 9.5. Motive Inc.
  • 9.6. Oxehealth
  • 9.7. Eight Sleep
  • 9.8. iHealth Labs

10. APPENDIX

  • 10.1. Currency
  • 10.2. Assumptions
  • 10.3. Base and Forecast Years Timeline
  • 10.4. Key Benefits for the Stakeholders
  • 10.5. Research Methodology
  • 10.6. Abbreviations